Naturecart Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-12-2024
- Paid Up Capital ₹ 50.00 K
as on 06-12-2024
- Company Age 4 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
About Naturecart Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ravikant Patil and Yogesh Patil serve as directors at the Company.
- CIN/LLPIN
U24290KA2021PTC142885
- Company No.
142885
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Naturecart Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravikant Patil  | Director | 06-Jan-2021 | Current |
| Yogesh Patil | Director | 06-Jan-2021 | Current |
Financial Performance of Naturecart Pharmaceutical.
Enhance accessibility to Naturecart Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Naturecart Pharmaceutical?
Unlock access to Naturecart Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sevasadan Lifeline Private LimitedActive 8 years 4 monthsRavikant Patil and Yogesh Patil are mutual person
Ndg-Sevasadan Super Speciality & Diabete S Hospital LlpActive 5 years 7 monthsRavikant Patil is a mutual person
- Sevasadan Healthplus Chikkodi Private LimitedActive 4 years 1 month
Ravikant Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Naturecart Pharmaceutical?
Naturecart Pharmaceutical has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naturecart Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naturecart Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.